In this study , we investigated the influence of the genetic polymorphisms GSTM1 , GSTT1 , and GSTP1 on treatment response in 94 Korean patients with de novo diffuse large B-cell lymphoma , who had received rituximab plus cyclophosphamide / doxorubicin / vincristine / prednisone ( R- CHOP ) as a front-line regimen .